CTOs on the Move

edmonds womens clinic

www.edmondswomensclinic.com

 
edmonds womens clinic is a Edmonds, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Allevex

Allevex is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KPI Ultrasound

KPI Ultrasound is a Riverside, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Neuronetics

Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is redefining patient and physician expectations with its NeuroStar Advanced Therapy for Mental Health. NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication hasn`t helped. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5 million treatments delivered. NeuroStar is backed by the largest clinical data set of any TMS system for depression, including the world`s largest depression Outcomes Registry. Neuronetics is committed to transforming lives by offering an exceptional treatment that produces extraordinary results.

Planmeca USA

Planmeca USA, a leading manufacturer of dental imaging and CAD/CAM equipment, recently moved its North American headquarters to a larger, high-tech facility that will house advanced training and facilitate innovation.

Neural Analytics

Neural Analytics was created in 2013 when the company`s co-founders were introduced to leading-edge technology in the UCLA Department of Neurology. Leo, Robert and Dan, along with key UCLA faculty and administrators, all saw the potential to commercialize this new technology and build an important company with the potential to help millions of patients around the world.